We are live on ! Find out more
BMRA icon

Biomerica

34 hedge funds and large institutions have $8.83M invested in Biomerica in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

17% more funds holding

Funds holding: 2934 (+5)

2.33% more ownership

Funds ownership: 25.75%28.08% (+2.3%)

23% less capital invested

Capital invested by funds: $11.5M → $8.83M (-$2.65M)

94% less call options, than puts

Call options by funds: $1K | Put options by funds: $18K

Holders
34
Holders Change
+5
Holders Change %
+17.24%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
11
Reduced
6
Closed
2
Calls
$1K
Puts
$18K
Net Calls
-$17K
Net Calls Change
-$177K

BMRA Hedge Fund Activity: Q1 2023 in Review

34 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q1 2023, worth a combined $8.83M — down 23% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BMRA positions and 2 closed out — a net gain of 6 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Potomac Capital Management, opening a new position worth an estimated $1.16M. The largest seller was Point72 Asset Management, cutting an estimated $512K.

  • 34 institutional investors held Biomerica (BMRA) as of Q1 2023, up from 29 in Q4 2022.
  • Funds reported $8.83M of Biomerica stock for Q1 2023, down 23% quarter-over-quarter.
  • 8 funds opened new Biomerica positions in Q1 2023 and 2 closed out, a net change of +6 holders.
  • The largest Biomerica buyer in Q1 2023 was Potomac Capital Management, an estimated $1.16M added.
  • The largest Biomerica seller in Q1 2023 was Point72 Asset Management, an estimated $512K sold.

Based on aggregated 13F filings for Q1 2023.